美國居民不適用 XM 服務。
D
D

DassaultSystem

財經新聞

France's Macron visits Serbia to boost EU ties, discuss Rafale deal 

France's Macron visits Serbia to boost EU ties, discuss Rafale deal  Macron and Vucic to discuss Rafale fighters, energy, AI Macron emphasizes Serbia's EU alignment amid Russia's war in Ukraine Serbian military diversifies from Soviet tech, seeks EU ties By Aleksandar Vasovic BELGRADE, Aug 29 (Reuters) - France's President Emmanuel Macron travels to Belgrade on Thursday to bolster ties with Serbia and bring it closer to the West, as the Balkan country juggles its European Union membership bid a
A
D
T

Ansys beats quarterly revenue and profit estimates on strong demand

Ansys beats quarterly revenue and profit estimates on strong demand July 31 (Reuters) - Ansys ANSS.O beat Wall Street estimates for second-quarter revenue and profit on Wednesday, driven by growing demand for its AI -powered tools and engineering software solutions. The company has benefited from surging demand for its simulation and analysis solutions that help in evaluating products virtually before their market launch.
A
D

BofA ups Dassault Systemes to 'buy' citing 'de-risked' guidance

BUZZ-BofA ups Dassault Systemes to 'buy' citing 'de-risked' guidance ** BofA Global Research upgrades Dassault Systemes DAST.PA to "buy" from "neutral" and raises its PT by 7.5% to 43 euros ** BofA says the company's 2024 guidance has been sufficiently de-risked, with both share prices and valuation close to four-year low ** On Thursday, Dassault S
D

Greencore, UCB, Unilever

EUROPE RESEARCH ROUNDUP-Greencore, UCB, Unilever July 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Greencore, UCB, and Unilever, on Friday. HIGHLIGHTS * Greencore GNC.L : HSBC raises target price to 190p from 160p * Lonza Group AG LONN.S : JP Morgan raises target price to CHF 645 from CHF 600 * Sartorius Stedim Biotech STDM.PA : HSBC cuts target price to EUR 310 from EUR 360 * UCB SA UCB.BR : TD Cowen raises target price to E
A
A
A
B
B
B
B
B
C
D
D
E
G
G
G
L
N
N
P
R
S
U
A
A
A
A
A
A
B
D
J

Eisai Selects Dassault Systemes's Medidata To Enhance Clinical Trial Efficiency, Patient Experience

BRIEF-Eisai Selects Dassault Systemes's Medidata To Enhance Clinical Trial Efficiency, Patient Experience July 25 (Reuters) - Dassault Systemes SE DAST.PA : EISAI SELECTS MEDIDATA’S CLINICAL DATA STUDIO TO ENHANCE AND MODERNIZE CLINICAL TRIAL EFFICIENCY AND PATIENT EXPERIENCE Source text for Eikon: ID:nBwJ7WR5a Further company coverage: DAST.PA (
D

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明